تحميل...
A Randomised Controlled Phase II Trial of the Combination of XELOX with Thalidomide for the First-line Treatment of Metastatic Colorectal Cancer
OBJECTIVE: To evaluate the efficacy and safety of the combination of XELOX regimen (oxaliplatin plus capecitabine) with thalidomide for the first-line treatment of metastatic colorectal cancer (MCRC). METHODS: All of the 89 patients with MCRC who fulfilled eligibility criteria were randomly assigned...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Chinese Anti-Cancer Association
2012
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3643658/ https://ncbi.nlm.nih.gov/pubmed/23691464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.005 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|